Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Teleflex acquires late-stage device company Eon Medical for its scar-reducing microlaparoscopy platform and lands European approval for its Arrow GPSCath balloon dilation catheter.
GE Healthcare is pouring $2 billion into a 5-year program to boost its software for healthcare systems and applications.
Bard’s poor organic growth has kept a lid on the stock when so many other medtechs have enjoyed big runs. Could a patent infringement settlement with Gore help turn the tide?
Hong Kong healthcare regulators flag 3 Boston Scientific products over typos in labeling and mismatched products.
Covidien is doubling down on emerging markets, expanding an investment program that the company had, at 1 point, thought would be over by the end of 2013.
J&J’s Michael Orsinger says the company has a long road ahead in the effort streamline the integration of Synthes, the medical giant’s largest-ever acquisition, which fetched a $19.7 billion price tag.
The FDA publishes the May 24 warning letter resulting from a month-long inspection of a Utah manufacturing facility, which resulted in 2 recalls but not much reaction from Wall Street.